Opendata, web and dolomites

Immune-Image SIGNED

Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Immune-Image project word cloud

Explore the words cloud of the Immune-Image project. It provides you a very rough idea of what is the project "Immune-Image" about.

clinically    barely    cell    chemists    physicists    synthesise    explored    immunotherapy    immune    validate    join    insights    drug    efficient    immunotherapeutics    disease    diverse    sustainable    vivo    assessing    immunotracers    decisions    flourishing    biomarkers    smart    drugs    forces    tracers    conduct    optimal    imaging    compliant    biologists    disciplinary    inflammatory    enhanced    assembled    workflows    gained    monitoring    quantitative    vary    create    trials    gmp    contribution    until    regulators    medical    good    status    modulation    played    diseases    technologists    immunologists    immunotherapies    optical    input    personalized    assure    believe    goals    pet    immunotracer    patient    blood    invasive    benefit    image    models    body    manufacturing    international    techniques    mri    cancer    treatments    unmet    specialists    treatment    pharmacists    emerged    platform    backgrounds    molecular    patients    tissue    clinical    rate    broadly    modest   

Project "Immune-Image" data sheet

The following table provides information about the project.

Coordinator
STICHTING VUMC 

Organization address
address: DE BOELELAAN 1117
city: AMSTERDAM
postcode: 1081 HV
website: www.vumc.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 27˙200˙801 €
 EC max contribution 15˙000˙000 € (55%)
 Programme 1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
 Code Call H2020-JTI-IMI2-2018-14-two-stage
 Funding Scheme IMI2-RIA
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2024-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    STICHTING VUMC NL (AMSTERDAM) coordinator 4˙079˙222.00
2    ACADEMISCH ZIEKENHUIS GRONINGEN NL (GRONINGEN) participant 2˙174˙208.00
3    WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER DE (MUENSTER) participant 1˙930˙000.00
4    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) participant 1˙103˙496.00
5    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) participant 1˙041˙875.00
6    VIB BE (ZWIJNAARDE - GENT) participant 885˙000.00
7    VRIJE UNIVERSITEIT BRUSSEL BE (BRUSSEL) participant 728˙329.00
8    FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES (BARCELONA) participant 514˙560.00
9    COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES FR (PARIS 15) participant 510˙000.00
10    STICHTING LYGATURE NL (UTRECHT) participant 450˙000.00
11    FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON ES (BARCELONA) participant 433˙310.00
12    LAWRENCIUM LEGAL BV NL (AMSTERDAM) participant 400˙000.00
13    TTOPSTART BV NL (UTRECHT) participant 400˙000.00
14    ANTAROS MEDICAL AB SE (MOLNDAL) participant 250˙000.00
15    EUROPEAN CANCER PATIENT COALITION BE (BRUXELLES) participant 100˙000.00
16    BAYER AKTIENGESELLSCHAFT DE (Leverkusen) participant 0.00
17    F. HOFFMANN-LA ROCHE AG CH (BASEL) participant 0.00
18    IMAGINAB, INC US (INGLEWOOD CA) participant 0.00
19    JANSSEN PHARMACEUTICA NV BE (BEERSE) participant 0.00
20    NOVARTIS PHARMA AG CH (BASEL) participant 0.00
21    PFIZER LIMITED UK (SANDWICH) participant 0.00
22    TAKEDA DEVELOPMENT CENTRE EUROPE LTD UK (LONDON) participant 0.00

Map

 Project objective

Immunotherapies have emerged as effective treatments for immune system-related diseases, such as cancer and inflammatory diseases. Although immunotherapeutics are effective not all patients benefit and side effects vary greatly. Thus, there is an unmet need for a personalized approach. Blood and tissue biomarkers have played only a modest role up until now in assessing immune status in vivo and we believe that non-invasive whole body imaging will make a significant contribution in the future. Although the field of imaging (PET, MRI, Optical Imaging) is flourishing, its application to patient immune status measurement and monitoring has barely been explored. Within Immune-Image we aim to develop new immunotracers for imaging specific immune cell subsets, develop quantitative imaging workflows, validate the immunotracers pre-clinically in relevant disease models, produce the tracers in a Good Manufacturing Practice (GMP)-compliant way, and conduct smart clinical trials, including with novel tracers. To this end, insights will be gained into the optimal use of drugs and a more efficient development of immunotherapeutics. Moreover, the success rate of immunotherapy development will be enhanced since our molecular imaging platform will provide novel insights into patient immune status, which will support drug development and treatment decisions. To achieve our goals, we have assembled an experienced international multi-disciplinary consortium composed of chemists, biologists, immunologists, physicists, pharmacists, information technologists, and medical specialists with diverse and essential backgrounds who will join forces to design, synthesise, evaluate and validate immunotracers and create sustainable molecular imaging techniques that can be broadly applied in the assessment of the immune status and immune modulation of patients. There will be input from patients and regulators in order to assure optimal design and execution of immunotracer clinical trials.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMMUNE-IMAGE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMMUNE-IMAGE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

NEURONET (2019)

Efficiently Networking European Neurodegeneration Research

Read More  

VITAL (2019)

Vaccines and Infectious Diseases in the Ageing PopuLation

Read More  

AB-DiRecT (2019)

Antibiotic Distribution and Recovery in Tissue

Read More